DKSH Acquires Healthcare Distributor Medipharm in Brunei

Media release

DKSH has signed an agreement to acquire Medipharm Sdn Bhd (“Medipharm”), one of the leading pharmaceutical and medical devices distributors in Brunei. With this acquisition, DKSH Healthcare grows its business in line with the strategy to expand its footprint in the Asia-Pacific region.

Zurich, Switzerland, January 15, 2024 – DKSH has announced today that it signed an agreement to acquire Medipharm, one of the leading pharmaceutical and medical devices distributors in Brunei. DKSH and Medipharm build on a longstanding strategic partnership, with Medipharm having operated as DKSH’s sub distributor in Brunei for the last 25 years.

Medipharm generates net sales of more than CHF 30 million¹ at good profitability. With a team of over 50 people, the company serves renowned blue-chip clients. Medipharm distributes pharmaceutical products, medical devices, consumer health, personal care, and nutritional products. Its main customers are hospitals, medical centers, clinics, opticians, and pharmacies.

Bijay Singh, Head Business Unit Healthcare, said: “With the integration of Medipharm, and Brunei being one of the few markets in Asia-Pacific with no direct presence of DKSH Healthcare, we further increase our footprint, enabling us to provide even more encompassing market coverage for our clients. We warmly welcome all Medipharm employees at DKSH and look forward to continuing our longstanding, successful partnership.”

Pengiran Sharinah, Chairwoman of Medipharm, commented: "Since Medipharm was founded in 1998, we have acted as a pivotal intermediary between our clients and customers in the distribution of life-saving drugs and medical products. The combination with DKSH marks the next milestone in our company history and will equally benefit our clients, employees, and business partners. We look forward to building on our joint expertise and continuing to pursue our journey of growth.”

¹ Exchange rate 1 Swiss Franc / 1.5 Brunei Dollar

About DKSH 
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with 32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,990 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2022. www.dksh.com/hec

For more information please contact:

DKSH Holding Ltd.

Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com

Melanie Grüter
Manager Group Media Relations
Phone +41 44 386 7211
melanie.grueter@dksh.com